China Gathers Research Intelligence For Next Five-Year Plan
This article was originally published in PharmAsia News
Executive Summary
The organizers of 863 Program recently held a strategic seminar on biomedical devices, biochips and nano-biotechnology for China's 12th five-year plan. Experts analyzed the world's development trends of these fields, examined key local academic institutions' research directions, as well as forecast the major requirements and progress of the sector during the five-year plan. Top executives from venture capitalists Morgan Stanley, WI Harper Group and Japan's SoftBank pointed out that China's life sciences research focus is in line with global market trends. They suggested that the next step should emphasize the commercialization of scientific achievements and their clinical applications. (Click here for more - Chinese Language)